Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid Inks Group Purchasing Deal with Novation

NEW YORK (GenomeWeb News) – Cepheid said today that it has signed a group purchasing deal with Novation for its GeneXpert System and Xpert MRSA (methicillin-resistant Staphylococcus aureus) tests.
 
Under the agreement, customers of Novation, a large group purchasing organization that serves hospital systems including VHA, University HealthSystem Consortium, and Provista, will be able to purchase the molecular diagnostics instrument and tests at undisclosed pre-negotiated prices. According to a Cepheid statement, Novation purchasing power represents 49 percent of admissions and 44 percent of staffed beds in the US.
 
The pact follows last week’s announcement of a similar arrangement between Cepheid and Premier, a group purchasing organization that has more than 1,500 hospitals in its network.
 

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.